Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review)

Glioblastoma is the most common and malignant subtype among all brain tumors. Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential component of cellular defense against a variety of endogenous and exogenous stresses. A marked increase in research over the past few decades focusing on N...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology reports 2014-08, Vol.32 (2), p.443-450
Hauptverfasser:	ZHU, JIANHONG, WANG, HANDONG, FAN, YOUWU, LIN, YIXING, ZHANG, LI, JI, XIANGJUN, ZHOU, MENGLIANG
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis Autophagy Brain cancer Brain research Cancer Care and treatment Chemotherapy Clinical Trials as Topic Enzymes Epidermal growth factor Gene Expression Regulation, Neoplastic - drug effects Genetic aspects glioblastoma Glioblastoma - drug therapy Glioblastoma - pathology Glioblastoma multiforme Health aspects Humans Hypoxia Kinases mechanism Nervous system NF-E2-Related Factor 2 - antagonists & inhibitors NF-E2-Related Factor 2 - metabolism Nrf2 Proteins Radiation therapy Signal transduction Signal Transduction - drug effects Stem cells Stress response Studies targeting therapy Tumor Microenvironment - drug effects Tumors Vascular endothelial growth factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!